Kaskela Law LLC is investigating Solid Biosciences Inc. (NASDAQ: SLDB) on behalf of the company’s shareholders.

Since February 2025, shares of Solid Biosciences’ common stock have declined in value from a trading price of over $6.00 per share to a current trading price of less than $4.50 per share, a decline of over 25% in value.

The investigation seeks to determine whether Solid Biosciences and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s investors in connection with recent corporate actions.

Solid Biosciences shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, to receive additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750